Literature DB >> 1211992

Prolonged secretion of lithogenic bile after cholecystectomy.

R M McDougall, K Walker, O G Thurston.   

Abstract

Hepatic bile samples were obtained from 8 subjects 1 1/2 to 23 years after cholecystectomy for presumed cholesterol gallstones. The content of cholesterol, bile acids and lecithin was determined for each bile sample and compared to the values found in gallbladder bile in 15 control subjects undergoing cholecystectomy for pure and mixed cholesterol stones. Plot of the data on triangular coordinates and subsequent determination of lithogenic index showed that bile was supersaturated with cholesterol in both groups of patients. The cholesterol content of bile remained at supersaturated levels following cholecystectomy and showed no tendency to return toward normal levels with the passage of time.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1211992      PMCID: PMC1343834          DOI: 10.1097/00000658-197508000-00012

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  13 in total

Review 1.  Medical therapy for gallstones.

Authors:  L J Schoenfield
Journal:  Gastroenterology       Date:  1974-10       Impact factor: 22.682

2.  Problems in the measurement of bile acids with 3 -hydroxysteroid dehydrogenase.

Authors:  R Engert; M D Turner
Journal:  Anal Biochem       Date:  1973-02       Impact factor: 3.365

3.  Bile acid pools, kinetics and biliary lipid composition before and after cholecystectomy.

Authors:  H R Almond; Z R Vlahcevic; C C Bell; D H Gregory; L Swell
Journal:  N Engl J Med       Date:  1973-12-06       Impact factor: 91.245

4.  The lithogenic index--a numerical expression for the relative lithogenicity of bile.

Authors:  A L Metzger; S Heymsfield; S M Grundy
Journal:  Gastroenterology       Date:  1972-03       Impact factor: 22.682

5.  Alterations in hepatic bile composition after cholecystectomy.

Authors:  F Simmons; A P Ross; I A Bouchier
Journal:  Gastroenterology       Date:  1972-09       Impact factor: 22.682

6.  Source of abnormal bile in patients with cholesterol gallstones.

Authors:  D M Small; S Rapo
Journal:  N Engl J Med       Date:  1970-07-09       Impact factor: 91.245

7.  Significance of the liver in the production of lithogenic bile in man.

Authors:  Z R Vlahcevic; C Bell; L Swell
Journal:  Gastroenterology       Date:  1970-07       Impact factor: 22.682

8.  Relationship of biliary phospholipid and cholesterol concentrations to the occurrence and dissolution of human gallstones.

Authors:  R K Tompkins; L G Burke; R M Zollinger; D G Cornwell
Journal:  Ann Surg       Date:  1970-12       Impact factor: 12.969

9.  Cholesterol solubility in bile. Evidence that supersaturated bile is frequent in healthy man.

Authors:  R T Holzbach; M Marsh; M Olszewski; K Holan
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

10.  The physicochemical basis of cholesterol gallstone formation in man.

Authors:  W H Admirand; D M Small
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

View more
  4 in total

1.  Impact of ursodeoxycholic acid on a CCK1R cholesterol-binding site may contribute to its positive effects in digestive function.

Authors:  Aditya J Desai; Maoqing Dong; Kaleeckal G Harikumar; Laurence J Miller
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-07-02       Impact factor: 4.052

Review 2.  Cholecystokinin-induced satiety, a key gut servomechanism that is affected by the membrane microenvironment of this receptor.

Authors:  A J Desai; M Dong; K G Harikumar; L J Miller
Journal:  Int J Obes Suppl       Date:  2016-11-16

3.  Effects of cholecystectomy on the kinetics of primary and secondary bile acids.

Authors:  F Berr; F Stellaard; E Pratschke; G Paumgartner
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

4.  Medical treatment of biliary duct stones: effect of ursodeoxycholic acid administration.

Authors:  G Salvioli; R Salati; R Lugli; C Zanni
Journal:  Gut       Date:  1983-07       Impact factor: 23.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.